# Yerxa Benjamin R: insider transactions

SEC CIK 1145910. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-27.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Opus Genetics, Inc.](/companies/ird.md) | President, Director, Officer | 2 | 2026-10-23 | 2026-10-23 |

## Transactions: 2

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-23 | [Opus Genetics, Inc.](/companies/ird.md) | Sale (S) | 25,520 | $3.5317 | $90.1k | [Form 4](/filings/0001140361-26-040906.md) |
| 2026-10-23 | [Opus Genetics, Inc.](/companies/ird.md) | Sale (S) | 7,669 | $3.5514 | $27.2k | [Form 4](/filings/0001140361-26-040906.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 13:07 ET. No prices; not investment advice.